TrialProstate cancer and prostatic diseases2022

Outcomes in men with metastatic castration-resistant prostate cancer who received sipuleucel-T and no immediate subsequent therapy: experience at Dana Farber and in the PROCEED Registry.

Xiao X Wei et al.PubMed ↗Publisher ↗

No numbers read from the abstract.